Clinic Korea · Dermatology
Comparison Guide · Rejuran vs. ProfhiloRejuran vs. Profhilo:
Two Regenerative Approaches Compared
Rejuran vs Profhilo is a closer comparison than Rejuran against fillers: both target skin quality rather than volume, which makes the distinction more subtle.
What’s the difference between Rejuran and Profhilo? Rejuran uses polynucleotides derived from salmon DNA to stimulate collagen production and cellular repair, while Profhilo uses a hybrid, high-concentration hyaluronic acid that spreads through tissue to boost hydration and stimulate skin cells differently. Both target skin quality rather than volume, but through distinct biological pathways.
Why These Two
Get Compared So Often
Rejuran and Profhilo are frequently mentioned together because neither adds volume the way a filler does; both aim to improve the skin’s underlying quality. The difference comes down to the active ingredient and how it interacts with tissue: Rejuran’s polynucleotides signal fibroblasts directly, while Profhilo’s hybrid hyaluronic acid works partly through hydration and partly through stimulating multiple cell types as it spreads. For the basics of what Rejuran itself involves, see our Rejuran Healer overview. For how Rejuran’s mechanism specifically works, see our Rejuran mechanism guide.
Rejuran vs. Profhilo
Side by Side
The table below compares the two across the dimensions that tend to matter most when choosing between similar regenerative options.
| Comparison Dimension | Rejuran | Profhilo |
|---|---|---|
| Primary Purpose | Stimulates collagen production and cellular repair | Boosts hydration and stimulates multiple skin cell types |
| Active Ingredient | Polynucleotides from purified salmon DNA | Hybrid, high-concentration hyaluronic acid |
| Injection Technique | Multiple microinjections across the treatment area | Typically five fixed injection points per side (BAP technique) |
| Commonly Discussed For | Texture, mild scarring, and early aging concerns | Hydration, skin laxity, and overall radiance |
| Typical Course | Usually three to four sessions, two to four weeks apart | Often two sessions spaced about a month apart initially |
| Downtime | Redness and small bumps for one to three days; a bruise, if one forms, can take about a week to fade | Small bumps at injection points that resolve within a day |
Typical schedules compared
Choosing Between
Two Similar-Sounding Options
If scarring, texture irregularities, or fine lines are the priority, Rejuran’s collagen-focused mechanism tends to be discussed as the more targeted option. If hydration and overall skin laxity are the bigger concern, Profhilo’s spreading hyaluronic acid formulation is often the one practitioners lean toward. Some clinics also alternate or combine the two across a broader skin plan.
For how Rejuran fits into a broader treatment routine generally, see our rejuvenation routine guide.
Two Different Materials
and Two Different Schedules
The comparison gets easier to hold onto once you separate what each product is made of from how often it is given, because those two things differ in ways that affect planning more than the marketing language does.
Rejuran’s active material is polynucleotide: purified DNA fragments, described in the clinical literature as derived from salmon sperm DNA, with tissue-repair and anti-inflammatory activity attributed to adenosine A2A receptor signalling. Profhilo belongs to a different family, the hybrid cooperative complexes of hyaluronic acid. A 2025 review in Pharmaceuticals describes these as delivering low- and high-molecular-weight hyaluronic acid together so that the two work in combination, held by cooperative hydrogen bonds that make the complex more resistant to hyaluronidase than high-molecular-weight hyaluronic acid on its own, and easier to push through a needle and spread in tissue.
The schedules diverge as well. Real-world reporting on the hyaluronic acid complexes commonly follows a two-session pattern (a treatment at baseline and a second at day 30, with assessment around day 90), and a 2025 patient-satisfaction evaluation across Malaysia, Singapore and Indonesia used exactly that structure. Polynucleotide courses run longer. A 2026 narrative review describes most studies using three to four sessions two to four weeks apart. A 2026 periorbital study gave two or three sessions three weeks apart, and a survey of Korean dermatologists using polynucleotides for scar management found three intradermal sessions the most common approach there.
That is the difference worth taking into a consultation. One is a hydrating, remodelling material on a short course; the other is a regenerative material usually given over more visits. If your trip is short, the schedule may settle the question before the ingredient does. A provider who tells you which is better without first asking how long you are in the country is answering a different question from the one you need resolved.
Frequently Asked
Questions
- Can Rejuran and Profhilo be used in the same treatment plan?
- Some practitioners do combine or alternate the two as part of a broader skin quality plan, though this should be sequenced by someone familiar with both treatments.
- Which one is better for very dry, dehydrated skin?
- Profhilo’s hyaluronic acid formulation is specifically built around hydration, so it’s often discussed as the more direct fit for that particular concern.
- Is one treatment more painful than the other?
- Both involve injections and are generally well tolerated, though the injection technique differs, which some patients find affects comfort differently.
- How many sessions does each treatment typically need?
- Profhilo is often described as needing fewer initial sessions, commonly two spaced about a month apart, while Rejuran courses usually run to three or four sessions two to four weeks apart, depending on the concern being addressed.
- Does either treatment work faster than the other?
- Both work gradually rather than instantly, since each relies on a biological process rather than adding physical volume; neither is designed to show dramatic same-day results.
Trying to Decide Between Two Similar Treatments?
Clinic Korea can help relay your questions to providers, arrange a consultation, and coordinate scheduling; the treatment decision itself stays between you and the provider.
Get Help Arranging a ConsultationSources
- Ziade et al., "Prospective Observational Study of Polynucleotide Injections for Periorbital Rhytides", Journal of Cosmetic Dermatology 25 (2026)
42 patients, 2 mL per session at 7.5 mg/mL, assessed with validated FACE-Q questionnaires at baseline and at one, three and six months. Improvements were significant at every follow-up point; adverse events, checked two days after each session, were minimal.
- Tintor et al., "Hybrid Cooperative Complexes of Low- and High-Molecular-Weight Hyaluronic Acid in Aesthetic Medicine", Pharmaceuticals 19 (2025)
Review of the technology behind Profhilo-type products: low- and high-molecular-weight hyaluronic acid delivered together, held by cooperative hydrogen bonds that resist hyaluronidase better than high-molecular-weight hyaluronic acid alone.
- Bee Lan et al., "Patient Satisfaction Using Hybrid Cooperative Complexes of Hyaluronic Acid for Neck Laxity", Plastic and Aesthetic Nursing 45 (2025)
Real-world evaluation across Malaysia, Singapore and Indonesia using the common two-session pattern: a treatment at baseline, a second at day 30, with physician assessment at day 30 and day 90.
- Rho et al., "Real-World Use of Polynucleotide Injections in Scar Prevention and Management: A Nationwide Survey of KAAD Dermatologists", Journal of Cosmetic Dermatology 25 (2026)
Survey of 501 Korean dermatologists. 73% used polynucleotides in scar management; intradermal injection over three sessions was the most common approach; combinations with toxin, fillers, corticosteroids, bleomycin and energy devices were frequent. Cost was the leading barrier. The authors describe the findings as hypothesis-generating.
- Arora, "Polynucleotides and polydeoxyribonucleotides in dermatology: A narrative review", Journal of Cutaneous and Aesthetic Surgery 19 (2026)
Reports that most polynucleotide studies used an initial phase of three to four sessions every two to four weeks, with redness or swelling for one to three days after intradermal injection.
Checked September 2026. Study findings are summarised in our own words; follow the links for the full papers and the limitations their authors state.
Related Guides
- What Is Rejuran Healer and How It Supports Skin Repair
- Who Should Avoid Rejuran, and Why
- Combining Rejuran With Other Treatments
- About Clinic Korea
Use This Page as a Starting Point
Session counts and schedules here describe common practice and published studies. The plan a provider proposes for your skin may differ, and the reason for any difference is worth asking about.
For background on the treatment discussed here, see Rejuran Healer as Part of a Broader Rejuvenation Routine.